Michelle C. Arnett MS, RDH , Massimo Costalonga DMD, PhD , Phonsuda Chanthavisouk MDT, BSDH , Michael D. Evans MS , Danna R. Paulson MSDH, RDH, CCRP
{"title":"Effect of scaling and root planing with and without minocycline hydrochloride microspheres on serum biomarkers and acute phase reactants","authors":"Michelle C. Arnett MS, RDH , Massimo Costalonga DMD, PhD , Phonsuda Chanthavisouk MDT, BSDH , Michael D. Evans MS , Danna R. Paulson MSDH, RDH, CCRP","doi":"10.1016/j.jfscie.2024.100040","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study tests the effects of scaling and root planing (SRP) vs SRP with minocycline hydrochloride microspheres (MMs) (SRP with MM) on serum biomarkers interleukin (IL)-1β, IL-6, tumor necrosis factor-α, and matrix metalloproteinase-8 and acute phase reactants hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>), high-sensitivity C-reactive proteins and haptoglobin (Hp) in patients with stage II-IV grade B periodontitis.</div></div><div><h3>Methods</h3><div>Seventy participants were randomized to receive SRP (n = 35) or SRP+MM (n = 35). Serum was collected at baseline (before SRP), 1-month reevaluation visit, and 3- and 6-month periodontal maintenance visits. MMs were delivered to pockets 5 mm or larger immediately after SRP and immediately after the 3-month periodontal maintenance visit. Serum for acute phase reactants only was collected at the 9- and 12-month posttreatment follow-up. All outcomes were summarized using estimated marginal means back-transformed to the original response scale with 95% CIs.</div></div><div><h3>Results</h3><div>At 6 months, no statistical significance was yielded in either group for IL-6 (<em>P</em> = .91), tumor necrosis factor-α (<em>P</em> = .34), or matrix metalloproteinase-8 (<em>P</em> = .34). IL-1β (<em>P</em> = .06) was slightly higher in the SRP-alone group, suggesting a clinical impact with the addition of MM. Acute phase reactants were not statistically significant for high-sensitivity C-reactive proteins (<em>P</em> = .59), HbA<sub>1c</sub> (<em>P</em> = .46), or haptoglobin (<em>P</em> = .22) for either group. These outcomes continued at the 9- and 12-month posttreatment follow-up.</div></div><div><h3>Conclusions</h3><div>SRP alone and SRP+MM minimally reduced levels of cytokine biomarkers and acute phase reactants in self-reported systemically healthy patients with advanced stages of periodontitis. Thresholds for resolution of local clinical inflammation may not have been achieved in this study to result in a reduction of systemic inflammation.</div></div>","PeriodicalId":73530,"journal":{"name":"JADA foundational science","volume":"3 ","pages":"Article 100040"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JADA foundational science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772414X24000100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
This study tests the effects of scaling and root planing (SRP) vs SRP with minocycline hydrochloride microspheres (MMs) (SRP with MM) on serum biomarkers interleukin (IL)-1β, IL-6, tumor necrosis factor-α, and matrix metalloproteinase-8 and acute phase reactants hemoglobin A1c (HbA1c), high-sensitivity C-reactive proteins and haptoglobin (Hp) in patients with stage II-IV grade B periodontitis.
Methods
Seventy participants were randomized to receive SRP (n = 35) or SRP+MM (n = 35). Serum was collected at baseline (before SRP), 1-month reevaluation visit, and 3- and 6-month periodontal maintenance visits. MMs were delivered to pockets 5 mm or larger immediately after SRP and immediately after the 3-month periodontal maintenance visit. Serum for acute phase reactants only was collected at the 9- and 12-month posttreatment follow-up. All outcomes were summarized using estimated marginal means back-transformed to the original response scale with 95% CIs.
Results
At 6 months, no statistical significance was yielded in either group for IL-6 (P = .91), tumor necrosis factor-α (P = .34), or matrix metalloproteinase-8 (P = .34). IL-1β (P = .06) was slightly higher in the SRP-alone group, suggesting a clinical impact with the addition of MM. Acute phase reactants were not statistically significant for high-sensitivity C-reactive proteins (P = .59), HbA1c (P = .46), or haptoglobin (P = .22) for either group. These outcomes continued at the 9- and 12-month posttreatment follow-up.
Conclusions
SRP alone and SRP+MM minimally reduced levels of cytokine biomarkers and acute phase reactants in self-reported systemically healthy patients with advanced stages of periodontitis. Thresholds for resolution of local clinical inflammation may not have been achieved in this study to result in a reduction of systemic inflammation.